Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 34.00
-0.80 (-2.30%)
Jul 9, 2026, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 12.51 billion as of July 9, 2026. Its market cap has decreased by -42.23% in one year.
Market Cap
12.51B
Enterprise Value
11.98B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.00
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 12.51B, an increase of 64.93%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 12.51B | -34.93% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 17.40B |
| Metis TechBio | 14.67B |
| Shaanxi Micot Pharmaceutical Technology | 13.63B |
| GenFleet Therapeutics (Shanghai) | 12.21B |
| Ascletis Pharma | 11.84B |
| TenNor Therapeutics (Suzhou) | 10.65B |
| HBM Holdings | 9.87B |
| Nanjing Leads Biolabs | 9.63B |